X0407 4 2023-04-24 0001860742 Bausch & Lomb Corp BLCO 0001974516 Stewart Andrew J. C/O BAUSCH + LOMB CORPORATION 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4 ONTARIO, CANADA 1 See remarks 0 Common Shares, No Par Value 2023-04-24 4 A 0 33150 0 A 33150 D Reflects the grant of restricted stock units ("RSUs") under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The Reporting Person's title as an officer of the Issuer is President, Ophthalmic Pharmaceuticals. /s/ Debra E. Levin, attorney-in-fact 2023-04-26